Patents by Inventor James S. Allan

James S. Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5304212
    Type: Grant
    Filed: January 10, 1992
    Date of Patent: April 19, 1994
    Assignee: Brigham and Women's Hospital
    Inventors: Charles A. Czeisler, Richard E. Kronauer, James S. Allan
  • Patent number: 5176133
    Abstract: A method for accurately assessing and rapidly modifying the phase and amplitude of the endogenous circadian pacemaker is disclosed. A circadian cycle modification capacity assessment method comprises (before and after a stimulus) eliminating activity-related confounding factors associated with the sleep-rest cycle which otherwise mask the state of the endogenous circadian pacemaker. Based on either individual or normative assessment data, the circadian phase and amplitude modification method involves the application of bright (about 9,500 lux) light and, advantageously, episodes of imposed darkness, at critically chosen phases to achieve rapid and stable changes in phase and amplitude. The timing of the episodes of bright light may be chosen either by reference to empirically-derived phase response data, or by using a mathematical model in which the endogenous circadian pacemaker is a van der Pol oscillator.
    Type: Grant
    Filed: June 15, 1989
    Date of Patent: January 5, 1993
    Assignee: Brigham and Women's Hospital
    Inventors: Charles A. Czeisler, Richard E. Kronauer, James S. Allan
  • Patent number: 5167228
    Abstract: A method for accurately assessing and rapidly modifying the phase and amplitude of the endogenous circadian pacemaker is disclosed. A circadian cycle modification capacity assessment method comprises (before and after a stimulus) eliminating activity-related confounding factors associated with the sleep-rest cycle which otherwise mask the state of the endogenous circadian pacemaker. Based on either individual or normative assessment data, the circadian phase and amplitude modification method involves the application of bright (about 9,500 lux) light and, advantageously, episodes of imposed darkness, at critically chosen phases to achieve rapid and stable changes in phase and amplitude. The timing of the episodes of bright light may be chosen either by reference to empirically-derived phase response data, or by using a mathematical model in which the endogenous circadian pacemaker is a second order differential equation of the van der Pol type, transformed into two complementary first order equations.
    Type: Grant
    Filed: May 9, 1990
    Date of Patent: December 1, 1992
    Assignee: Brigham and Women's Hospital
    Inventors: Charles A. Czeisler, Richard E. Kronauer, James S. Allan
  • Patent number: 5163426
    Abstract: A method for accurately assessing and rapidly modifying the phase and amplitude of the endogenous circadian pacemaker is disclosed. A circadian cycle modification capacity assessment method comprises (before and after a stimulus) eliminating activity-related confounding factors associated with the sleep-rest cycle which otherwise mask the state of the endogenous circadian pacemaker. Based on either individual or normative assessment data, the circadian phase and amplitude modification method involves the application of bright (about 9,500 lux) light and, advantageously, episodes of imposed darkness, at critically chosen phases to achieve rapid and stable changes in phase and amplitude. The timing of the episodes of bright light may be chosen either by reference to empirically-derived phase response data, or by using a mathematical model in which the endogenous circadian pacemaker is a van der Pol oscillator.
    Type: Grant
    Filed: June 26, 1987
    Date of Patent: November 17, 1992
    Assignee: Brigham and Women's Hospital
    Inventors: Charles A. Czeisler, Richard E. Kronauer, James S. Allan